TN-DIGITAL-REASONING
Uday Kamath, an experienced data scientist and machine learning expert, joins Digital Reasoning as the company’s chief analytics officer (CAO). In this new role, Kamath will lead a dedicated team focused on driving innovation in data analytics and artificial intelligence (AI) technologies, while also working closely with product and engineering departments across Digital Reasoning .
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170926005631/en/
“AI and analytics innovation is the core of what we do at Digital Reasoning, and it’s important for our company to have strong leaders like Uday to ensure innovation in these areas remained at the forefront of our business,” said Digital Reasoning CEO Brett Jackson. “With his extensive technical background and broad industry knowledge, Uday will connect all facets of Digital Reasoning to one AI-driven strategy for improved company growth.”
Building on Digital Reasoning’s proven success, Kamath will lead the company’s AI and analytics strategy and will help to drive continued AI innovation across the company’s portfolio of industry leading analytics and insights solutions.
“I’ve built my career around innovations in machine learning and data analytics technologies, and taking the lead as the CAO at Digital Reasoning allows me to apply my expertise to the biggest questions regarding the future of AI,” said Kamath. “I’m excited by the opportunity to join a world-class cognitive computing company, and look forward to working with dedicated teams across the business to develop and execute an aggressive analytics strategy that ensures we not only remain competitive, but are also driving the best results for our customers.”
Kamath has more than 20 years of experience architecting and building analytics-based solutions. Most recently, he served as the chief data scientist at BAE Systems Applied Intelligence, building machine learning products and solutions for the financial industry, focused on fraud, compliance and cybersecurity. Prior to that, Kamath served as an analytics architect at Norkom Technologies where he managed overall architecture of products and customer implementations. His Ph.D. in Big Data Machine Learning was one of the first in generalized scaling of machine learning algorithms.
About Digital Reasoning
Digital Reasoning is a global leader in using artificial intelligence to understand human communications. Our award-winning cognitive computing platform, Synthesys®, automates key tasks and uncovers transformative insights across vast amounts of human communications for many of the world’s most elite companies, organizations, and agencies.
Our technology has been proven to find critical risks and valuable revenue-generating opportunities, delivering rapid and large return on investment in the most complex big data and analytical environments.
Digital Reasoning is headquartered in Nashville, Tennessee, and has offices in Washington, D.C., New York, and London. www.digitalreasoning.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170926005631/en/
Contact:
Digital Reasoning
Jason Beck, 615-567-8633
jason.beck@digitalreasoning.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release
Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom